These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36945332)

  • 1. Expression of miR-221 and miR-18a in patients with hepatocellular carcinoma and its clinical significance.
    Yun JH; Baek MJ; Jung HI
    Korean J Clin Oncol; 2022 Jun; 18(1):17-26. PubMed ID: 36945332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between expression levels of lncRNA UCA1 and miR-18a with prognosis of hepatocellular cancer.
    Zhang Z; Li JZ; Wei ZW; Li F; Li HM; Xiao Y; Qin YQ
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3586-3591. PubMed ID: 32329833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10.
    Wang X; Lu J; Cao J; Ma B; Gao C; Qi F
    Onco Targets Ther; 2018; 11():7919-7934. PubMed ID: 30519035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation.
    Morita K; Shirabe K; Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Ikegami T; Yamashita Y; Sugimachi K; Harimoto N; Itoh S; Ikeda T; Maehara Y
    Liver Transpl; 2016 May; 22(5):665-76. PubMed ID: 26783726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma.
    Elghoroury EA; Abdelghaffar EE; Awadallah E; Kamel SA; Kandil D; Hassan EM; Hassan M; Kamel MM; Gomaa MM; Fathalla LA
    Int J Immunopathol Pharmacol; 2022; 36():3946320221097832. PubMed ID: 35467432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between underexpression of microrna-203 and clinicopathological significance in hepatocellular carcinoma tissues.
    Liu Y; Ren F; Rong M; Luo Y; Dang Y; Chen G
    Cancer Cell Int; 2015; 15():62. PubMed ID: 26109910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.
    Rong M; Chen G; Dang Y
    BMC Cancer; 2013 Jan; 13():21. PubMed ID: 23320393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.
    Pan L; Huang S; He R; Rong M; Dang Y; Chen G
    Eur J Med Res; 2014 Dec; 19(1):68. PubMed ID: 25444499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues.
    Rong M; He R; Dang Y; Chen G
    Ups J Med Sci; 2014 Mar; 119(1):19-24. PubMed ID: 24172202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of microRNA-196b-5p in Hepatocellular Carcinoma and its Potential Molecular Mechanism.
    Zhang L; Luo B; Dang YW; He RQ; Peng ZG; Chen G; Feng ZB
    J Cancer; 2019; 10(22):5355-5370. PubMed ID: 31632480
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical significance of microRNA 138 and cyclin D3 in hepatocellular carcinoma.
    Huang B; Li H; Huang L; Luo C; Zhang Y
    J Surg Res; 2015 Feb; 193(2):718-23. PubMed ID: 25439221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4.
    Liu L; Cai X; Liu E; Tian X; Tian C
    Oncotarget; 2017 Sep; 8(40):68263-68269. PubMed ID: 28978114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study.
    Huang WT; Wang HL; Yang H; Ren FH; Luo YH; Huang CQ; Liang YY; Liang HW; Chen G; Dang YW
    Onco Targets Ther; 2016; 9():5163-80. PubMed ID: 27578984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance.
    Cheng J; Chen Y; Zhao P; Li N; Lu J; Li J; Liu Z; Lv Y; Huang C
    Oncol Lett; 2017 May; 13(5):3859-3865. PubMed ID: 28529597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma.
    Li CL; Yeh KH; Liu WH; Chen CL; Chen DS; Chen PJ; Yeh SH
    Int J Cancer; 2015 Feb; 136(4):761-70. PubMed ID: 24975878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients.
    Tian LL; Qian B; Jiang XH; Liu YS; Chen T; Jia CY; Zhou YL; Liu JB; Ma YS; Fu D; Ding ST
    Int J Genomics; 2021; 2021():6670390. PubMed ID: 33816607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-328 enhances cellular motility through posttranscriptional regulation of PTPRJ in human hepatocellular carcinoma.
    Luo X; Yang S; Zhou C; Pan F; Li Q; Ma S
    Onco Targets Ther; 2015; 8():3159-67. PubMed ID: 26604785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.